Literature DB >> 11059617

Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure.

N Mabuchi1, T Tsutamoto, K Maeda, M Kinoshita.   

Abstract

To determine changes in plasma brain natriuretic peptide (BNP) after direct current cardioversion (DC) and to evaluate the relationship between plasma atrial natriuretic peptide (ANP) and BNP and the recurrence of atrial fibrillation (AF) after DC in patients with mild congestive heart failure (CHF), plasma ANP and BNP were measured before and after DC in 71 patients with mild CHF and then followed. In 65 patients with successful DC, both ANP and BNP decreased 15 min after DC. Cox stepwise multivariate analysis among 14 variables such as age, history of AF, echocardiographic parameters, medication and ANP and BNP revealed that only low ANP (p=0.005) and high BNP before DC (p=0.0002) were independent predictors of recurrent AF. A ratio of ANP to BNP less than 0.44 was a significant risk factor for AF recurrence by Kaplan-Meier analysis (p=0.02). BNP began to decrease immediately after successful DC. High BNP and relatively low ANP compared with BNP were independent risk factors of AF recurrence in patients with mild CHF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059617     DOI: 10.1253/jcj.64.765

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  10 in total

1.  Level Of Natriuretic Peptide Determines Outcome In Atrial Fibrillation.

Authors:  Qi-Xian Zeng; Ming-Fen Wei; Wei Zhang; Yun Zhang; Jing-Quan Zhong
Journal:  J Atr Fibrillation       Date:  2010-01-01

2.  Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation.

Authors:  T Date; T Yamane; K Inada; S Matsuo; S Miyanaga; K Sugimoto; K Shibayama; I Taniguchi; S Mochizuki
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

3.  N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.

Authors:  F W Asselbergs; M P van den Berg; S J Bakker; J E Signorovitch; H L Hillege; W H van Gilst; D J van Veldhuisen
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

4.  Brain natriuretic peptide and P wave duration in dialysis patients.

Authors:  M Cagatay Taskapan; Soner Senel; Ozkan Ulutas; Yuksel Aksoy; Ibrahim Sahin; Feridun Kosar; Hulya Taskapan
Journal:  Int Urol Nephrol       Date:  2007-04-25       Impact factor: 2.370

5.  Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma.

Authors:  Jiang-Long Hou; Ke Gao; Mei Li; Jian-Yang Ma; Ying-Kang Shi; Yun Wang; Yong-Fan Zhao
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Peak Early Diastolic Transmitral Velocity As A Surrogate Marker Of Short-Term Atrial Fibrillation Recurrence After Electrical Cardioversion.

Authors:  Christos Varounis; Themistoklis Maounis; Dennis V Cokkinos
Journal:  J Atr Fibrillation       Date:  2015-12-31

7.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

Review 8.  Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis.

Authors:  Xiangdong Xu; Yongqing Tang
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

9.  Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.

Authors:  Kazuomi Kario; Satoshi Hoshide; Kazuaki Uchiyama; Tetsuro Yoshida; Osamu Okazaki; Takao Noshiro; Hirotaka Aoki; Hiroyuki Mizuno; Yuri Matsumoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-16       Impact factor: 3.738

10.  Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease.

Authors:  Masafumi Sato; Akihito Mikamo; Hiroshi Kurazumi; Ryo Suzuki; Masanori Murakami; Toshiro Kobayashi; Koich Yoshimura; Kimikazu Hamano
Journal:  J Cardiothorac Surg       Date:  2013-02-28       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.